Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

DoubleTree Bethesdan

Sep 23, 2019 7:00 AM - Sep 24, 2019 5:00 PM

8120 Wisconsin Avenue, , Bethesda, MD 20814 , USA

Biosimilars Conference

Session 4: Overcoming Barriers- Knowledge/Perception

Session Chair(s)

Hillel P Cohen, PhD

Hillel P Cohen, PhD

Executive Director, Scientific Affairs

Sandoz Inc., United States

This session will provide insights into the current knowledge and perception of different stakeholders about biosimilars, including patients and their healthcare providers. The FDA, a patient advocacy group and a physician group, will discuss targeted educational initiatives that are being undertaken to educate different stakeholders about key concepts of biosimilarity to address topics and issues that are often misunderstood. The session will consist of brief presentations, followed by a panel discussion that will provide the audience with the opportunity to pose questions to the panelists to initiate further discussion.

Learning Objective :
  • List those biosimilar concepts that are already familiar to stakeholders as well as concepts for which education is still needed
  • Describe the new initiatives that are being undertaken in the near future to increase biosimilar knowledge and enhance a positive perception of biosimilars
  • Employ useful tools that can be used to combat misinformation about biosimilars
  • Identify how different stakeholder groups can support the education campaigns of each other


Sarah  Crowley-Ikenberry, MA


Sarah Crowley-Ikenberry, MA

FDA, United States

Senior Communication Advisor, OTBB, OND, CDER

Cheryl  Koehn


Cheryl Koehn

Arthritis Consumer Experts, Canada

Founder and President

Angus  Worthing, MD


Angus Worthing, MD

American College of Rheumatology, United States

Chair, Government Affairs Committee

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.